Latest Zimmer Holdings Inc. Stories
WARSAW, Ind., June 14, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced that its Board of Directors has authorized the payment of a cash dividend to stockholders for the second quarter of 2013. The cash dividend of $0.20 per share will be paid on or about July 26, 2013, to stockholders of record as of the close of business on June 28, 2013. The dividend represents an annual dividend rate of 80 cents per...
WARSAW, Ind., May 3, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal healthcare, announced that it will be participating in the Deutsche Bank Securities 38th Annual Health Care Conference at The Westin Boston Waterfront Hotel in Boston, Massachusetts on May 29, 2013, at 9:20 a.m. Eastern Time. A live webcast of the presentation can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com. The webcast will...
Zimmer Expands Portfolio of Technologies Addressing the Continuum of Care for Knee Patients with Addition of Unique Subchondral Joint Preservation Treatment WARSAW, Ind., May 2, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has acquired the business assets of West Chester, Pennsylvania-based Knee Creations, LLC. The acquisition enhances Zimmer's product portfolio of knee treatments through the addition of Knee Creations' Subchondroplasty(®)...
WARSAW, Ind., April 25, 2013 /PRNewswire/ -- Net Sales of $1,139 million represent a decrease of 0.2% reported from the prior year period (an increase of 1.0% constant currency) Diluted EPS for the first quarter were $1.28 reported, an increase of 9.4% over the prior year period, and $1.41 adjusted, an increase of 8.5% over the prior year period Company reaffirms constant currency revenue and EPS guidance and updates reported revenue guidance for 2013 Zimmer Holdings, Inc. (NYSE:...
WARSAW, Ind., April 4, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today its first quarter 2013 sales and earnings conference call will be broadcast live over the Internet on Thursday, April 25, 2013, at 8:00 a.m. Eastern Time. A news release detailing the quarterly results will be made available at 7:00 a.m. Eastern Time the morning of the conference call. The live audio webcast can be accessed via Zimmer's Investor Relations website at...
The Zimmer Institute has Provided Product, Technology and Surgical Technique Training to over 100,000 surgeons CHICAGO, March 22, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, is celebrating the 10-year anniversary of The Zimmer Institute. The Zimmer Institute offers orthopaedic surgeons and healthcare professionals a full range of training opportunities, including Medical Education, BioSkills Training and...
Innovative New Ankle Replacement Employs a Low Profile Design and Lateral Surgical Approach CHICAGO, March 21, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, today introduced the Zimmer® Trabecular Metal(TM) Total Ankle, a complete ankle replacement and instrument system, at the 2013 American Academy of Orthopaedic Surgeons annual meeting. The Zimmer Trabecular Metal Total Ankle is designed to restore alignment, reduce...
Proprietary process from Zimmer delivers unmatched oxidative stability, ultra-low wear rates and exceptional strength in new bearing material with Vitamin E CHICAGO, March 21, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, is highlighting Vivacit-E® Advanced Bearing Technology with Vitamin E at the 2013 American Academy of Orthopaedic Surgeons annual meeting. Vivacit-E material is formulated with antioxidant protection to...
Gel-One® Offers Knee Arthritis Sufferers Pain Relief and Restored Mobility in a Single Injection CHICAGO, March 20, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, today introduced Gel-One® Cross-linked Hyaluronate at the 2013 American Academy of Orthopaedic Surgeons Annual Meeting. Gel-One Hyaluronate is an injectable gel approved for the treatment of osteoarthritis of the knee. The product is the first low-volume...
Persona Knee Replacement Replicates the Anatomy and Biomechanics of the Knee for a Better Fit, More Natural Feel and More Normal Function CHICAGO, March 20, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal health, today introduced Persona The Personalized Knee System, at the 2013 American Academy of Orthopaedic Surgeons Annual Meeting. The Persona System ushers in a new era in total knee replacement, combining personalized implants...
